Article Information
History
- October 28, 2020.
Article Versions
- Version 1 (October 12, 2020 - 23:11).
- You are currently viewing Version 2 of this article (October 28, 2020 - 00:27).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Audrey M. Hendley1,
- Arjun A. Rao2,3,13,
- Laura Leonhardt1,13,
- Sudipta Ashe1,13,
- Jennifer A. Smith1,
- Simone Giacometti1,
- Xianlu L Peng4,5,
- Honglin Jiang6,
- David I. Berrios1,
- Mathias Pawlak7,
- Lucia Y. Li1,
- Jonghyun Lee1,
- Eric A. Collisson6,
- Mark Anderson1,
- Gabriela K. Fragiadakis2,3,8,
- Jen Jen Yeh4,5,9,
- Jimmie Ye Chun10,
- Grace E. Kim11,
- Valerie M. Weaver12 and
- Matthias Hebrok1,*
- 1Diabetes Center, University of California, San Francisco, San Francisco, California, USA
- 2CoLabs, University of California, San Francisco, California, USA
- 3Bakar ImmunoX Initiative, University of California, San Francisco, California, USA
- 4Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- 5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- 6Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, USA
- 7Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts, USA
- 8Department of Medicine, Division of Rheumatology, University of California, San Francisco, California, USA
- 9Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- 10Parker Institute for Cancer Immunotherapy, San Francisco, California, USA
- 11Department of Pathology, University of California, San Francisco, San Francisco, California, USA
- 12Center for Bioengineering and Tissue Regeneration, UCSF, San Francisco, California, USA
- ↵*Correspondence: Matthias.Hebrok{at}ucsf.edu
↵13 These authors contributed equally.